Everyday foundations · Research Analysis
The MIND diet trial found no cognitive edge over its active control
Both groups improved while receiving counseling, calorie restriction and weight-loss support. The small between-group cognitive difference was not statistically significant, and MRI measures were similar.
Discovery, counterevidence, claim mapping, identifiers, funding, correction state and prose were reviewed before release.
Evidence box
Randomized null result against an active dietary control
- Study type
- Randomized controlled dietary trial
- Studied in
- Adults age 65+ without cognitive impairment who had family dementia history, BMI above 25 and a suboptimal diet
- Participants / sample
- 604 randomized; 93.4% completed the three-year trial
- Publication status
- Peer-reviewed primary reports and current registry records; correction status checked August 2, 2026
- Outcome type
- Global cognition and structural MRI measures over three years
- Development stage
- Completed human dietary trial; not a demonstrated dementia-prevention treatment
- Conflicts / funding
- National Institute on Aging; investigators disclosed donated foods and product support
- Our assessment
- No detected cognitive or MRI advantage over the active control; dementia, healthspan and lifespan were not tested
- Reporting confidence
- High for the randomized comparison; low for claims beyond the measured endpoints
Start here
Key takeaways
- Global cognition changed by +0.205 standard units with MIND and +0.170 with control; the adjusted difference was 0.035 (95% CI −0.022 to 0.092; p=.23).
- Both groups received counseling, a 250-kcal-per-day restriction goal and weight-loss support.
- MRI measures were similar; the trial did not test dementia prevention or lifespan.
Keep the outcomes separate
What we know / what we do not know
What we know
- The randomized trial did not detect a significant three-year cognitive advantage for MIND over its active control.
- Retention was high, and both groups lost weight and improved their diet scores.
What we do not know
- Whether a different population, adherence level, duration or comparator would yield a different result.
- Whether the diet prevents dementia, preserves independence, changes mortality, or extends life.
Evidence at a glance
The answer changes with the outcome.
Rows preserve outcome boundaries; they are not a score, ranking, or recommendation.
| Outcome | Result | Boundary |
|---|---|---|
| Global cognition | Difference 0.035 standardized units (95% CI −0.022 to 0.092; p=.23). | No significant advantage over the active control. |
| MRI structure | White-matter, hippocampal and total gray/white-matter measures were similar. | A structural scan is not dementia incidence or daily function. |
| Dementia and lifespan | Not tested. | Observational associations cannot substitute for this randomized endpoint. |
The bottom line
The three-year MIND diet trial did not find a statistically significant cognitive advantage over an active control. Global cognition improved in both groups; the adjusted between-group difference was 0.035 standardized units (95% CI −0.022 to 0.092; p=.23). MRI measures were also similar.
Why this matters
Observational studies have linked MIND-style eating patterns with better cognitive outcomes. A randomized test asks a harder question: did assignment to the MIND program outperform the comparison program? Here, that answer was no detected difference—not proof that diet never matters.
What researchers did
The trial enrolled 604 older adults without cognitive impairment but with family dementia history, overweight status and a suboptimal diet. Both groups received regular counseling, a 250-kcal-per-day restriction goal and weight-loss support. The contrast was MIND versus another active diet program, not diet change versus doing nothing.
What they found
Three-year global-cognition change was +0.205 standardized units with MIND and +0.170 with control. The confidence interval crossed zero. White-matter hyperintensity volume, hippocampal volume and total gray and white matter were similar. Adverse-event burden was reported as similar.
How strong is the evidence?
Randomization, a prespecified comparison and high completion support the primary result. The active comparator may have reduced the contrast between groups, but that feature is part of the question the trial actually answered. Post-hoc adherence analyses cannot overwrite the randomized comparison.
What this study does not show
The trial did not test dementia prevention, independence, biological-age reversal, healthspan or lifespan. A null result also does not prove that no version of the dietary pattern can affect cognition in any population.
Safety, interpretation, and funding
Dietary patterns interact with weight, nutritional needs, medications and medical conditions. The trial was funded by the National Institute on Aging and disclosed donated foods and product support. This evidence summary is not individualized dietary advice.
What happens next
Future trials can test longer follow-up, clinical dementia and function outcomes, different comparators, and whether prespecified adherence strategies change the randomized effect without relying on post-hoc selection.
Primary sources
Sources, roles and limits
- Barnes et al., randomized MIND diet trial
- Identifier
- PMID:37466280 · PMCID:PMC10513737 · DOI:10.1056/NEJMoa2302368 · NCT02817074
- Role
- Primary randomized null evidence
- Limitation
- Active calorie-restricted comparator; cognition and MRI, not dementia or lifespan.
- Open full-text trial report
- Identifier
- PMCID:PMC10513737 · DOI:10.1056/NEJMoa2302368
- Role
- Full methods, results, MRI, adverse-event, funding and disclosure verification
- Limitation
- This is the same primary trial report, not independent replication.
- ClinicalTrials.gov record
- Identifier
- NCT02817074
- Role
- Registry identity and study history
- Limitation
- Registration is not government validation of safety or efficacy.
Connected topics
Continue through the knowledge system
Continue with real coverage
Keep reading
These are learning paths, not rankings, recommendations, or evidence that the stories support one another.
Another dietary pattern where randomized and observational evidence stay distinct
PREDIMED found fewer cardiovascular events after a Mediterranean-style diet—with a correction history
The corrected randomized analysis is promising for its composite endpoint, while allocation deviations and lifespan limits remain visible.
Evidence scopeHuman clinical outcomes · corrected randomized trial
An eating-pattern trial with an active comparator question
Human time-restricted-eating trials show mixed short-term results—not slower aging
Different eating windows and comparators produced different weight and fat findings; none tested biological aging, healthspan or lifespan.
Evidence scopeHuman outcomes · short randomized trials
Another cognitive-aging question without a dementia endpoint
Multivitamins moved some tests and aging clocks. What does that mean?
COSMOS found small cognitive-test differences and modest movement in two DNA-methylation clocks; neither establishes dementia prevention or longer life.
Evidence scopeHuman cognitive tests and biomarkers · correlated randomized substudies
Disclosures and history
- August 2, 2026 — source discovery, verification and counterevidence completed before prose drafting.
- August 2, 2026 — atomic claim map, article draft, identifiers, funding, correction state and inference boundaries reviewed.
- Corrections: none identified for the MIND randomized report or registry record as of publication.